SCHERING-PLOUGH PHARMACEUTICAL PRESIDENT CONKLIN TO HEAD OTC GROUP

SCHERING-PLOUGH PHARMACEUTICAL PRESIDENT CONKLIN TO HEAD OTC GROUP under a top-level management reshuffling announced July 7. Effective Sept. 1, Schering-Plough Exec VP Donald Conklin, 57, who has directed the company's worldwide prescription drug business since 1986, will become president of Schering-Plough HealthCare, replacing David Collins. Schering-Plough HealthCare's brands include Coppertone, Shade and Tropical Blend sunscreens and Dr. Scholl's foot care products.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight